Sign In for increased benefits

Turn your one-off questions into a powerhouse research hub.

  • 🚨Real-time alerts on your custom watchlists
  • 🔍Unlock Deep Research Mode
  • 📊Exportable PDF/Word reports
  • 📚Revisit every question in your account history
  • ⭐Get personalised research and news based on your past questions
  • 🤝Team collaborate & annotate insights
  • 🌐Sync across devices—never lose your place
  • 👑Early-access to the next big AI features
  • 📚Continue enjoying 40 questions daily on your free account
About UsFAQsContact UsPrivacy PolicyCookies PolicyTerms and ConditionAcceptable Use PolicyData Processing Addendum
📢 New Earnings In! 🔍
Latest EarningsEarnings ChatEarnings FeedCompanies

AbCellera Biologics Inc.

ABCL

Healthcare
Biotechnology
CA

Company Overview

Detailed information about AbCellera Biologics Inc.

Basic Information
Ticker: ABCL
Country: CA
Headquarter: Vancouver, BC
Employees: 586
Financial Information
Market Cap: $1 Billion
Currency: USD
Sector: Healthcare
Industry: Biotechnology

Stock Data provided by Financial Modeling Prep

Company Description

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Last Updated: Jul 2025

Here's what you can ask